These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35319342)
21. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers. Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551 [TBL] [Abstract][Full Text] [Related]
22. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment. Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069 [TBL] [Abstract][Full Text] [Related]
23. Triple stimuli-responsive keratin nanoparticles as carriers for drug and potential nitric oxide release. Li Y; Lin J; Zhi X; Li P; Jiang X; Yuan J Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():606-614. PubMed ID: 30033293 [TBL] [Abstract][Full Text] [Related]
24. Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery. Eskandari P; Bigdeli B; Porgham Daryasari M; Baharifar H; Bazri B; Shourian M; Amani A; Sadighi A; Goliaei B; Khoobi M; Saboury AA J Drug Target; 2019 Dec; 27(10):1084-1093. PubMed ID: 30900473 [TBL] [Abstract][Full Text] [Related]
25. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery. Li X; Xie C; Xia H; Wang Z Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720 [TBL] [Abstract][Full Text] [Related]
27. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system. Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882 [TBL] [Abstract][Full Text] [Related]
28. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery. Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810 [TBL] [Abstract][Full Text] [Related]
29. Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery. Cheng YJ; Zhang AQ; Hu JJ; He F; Zeng X; Zhang XZ ACS Appl Mater Interfaces; 2017 Jan; 9(3):2093-2103. PubMed ID: 28032742 [TBL] [Abstract][Full Text] [Related]
30. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo. Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575 [TBL] [Abstract][Full Text] [Related]
31. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819 [TBL] [Abstract][Full Text] [Related]
32. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy. Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681 [TBL] [Abstract][Full Text] [Related]
33. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery. Yuan X; Peng S; Lin W; Wang J; Zhang L J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647 [TBL] [Abstract][Full Text] [Related]
34. Optimized mesoporous silica nanoparticle-based drug delivery system with removable manganese oxide gatekeeper for controlled delivery of doxorubicin. Miao Y; Feng Y; Bai J; Liu Z; Zhao X J Colloid Interface Sci; 2021 Jun; 592():227-236. PubMed ID: 33662827 [TBL] [Abstract][Full Text] [Related]
35. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells. Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642 [TBL] [Abstract][Full Text] [Related]
36. A convergent fabrication of pH and redox dual-responsive hybrids of mesoporous silica nanoparticles for the treatment of breast cancer. Zhu L; Wang S J Biomater Sci Polym Ed; 2023 Feb; 34(2):147-165. PubMed ID: 36136033 [TBL] [Abstract][Full Text] [Related]
37. Dual stimuli-responsive mesoporous silica nanoparticles for efficient loading and smart delivery of doxorubicin to cancer with RGD-integrin targeting. Kim HS; Kang JH; Jang J; Lee EJ; Kim JH; Byun J; Shin US Eur J Pharm Sci; 2023 Sep; 188():106525. PubMed ID: 37437854 [TBL] [Abstract][Full Text] [Related]
38. pH/GSH-Dual-Sensitive Hollow Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Cancer Therapy. Chen Z; Wan L; Yuan Y; Kuang Y; Xu X; Liao T; Liu J; Xu ZQ; Jiang B; Li C ACS Biomater Sci Eng; 2020 Jun; 6(6):3375-3387. PubMed ID: 33463161 [TBL] [Abstract][Full Text] [Related]
39. The thermal/pH-sensitive drug delivery system encapsulated by PAA based on hollow hybrid nanospheres with two silicon source. Zhang K; Zhang Y; Li Y; Iqbal Z; Yu L; Liu J; Wang H; He P J Biomater Sci Polym Ed; 2021 Apr; 32(6):695-713. PubMed ID: 33297850 [TBL] [Abstract][Full Text] [Related]